瑞替加濱對缺血性腦卒中模型大鼠星形膠質(zhì)細胞及Caspase-3的表達影響
[Abstract]:Objective to compare the changes of cerebral infarction volume by Longa5. The number of (GFAP) positive cells (astrocytes) and the number of apoptotic protease-3 (Caspase-3) positive cells were detected by immunohistochemistry. Objective: to investigate the effect of retegabine on the expression of Caspase-3 in cerebral infarction rats, and to explore the protective effect and mechanism of retegabine (Retigabine RTG) on ischemic stroke rats. Methods Seventy-five SD rats were randomly divided into sham-operated group (15 rats), model group (15 rats) and intervention group (45 rats). According to the time of administration after reperfusion, the intervention group was divided into RTG 0 h group and 1 h group with 15 rats in each group. The drug was administered through the tail vein of rats. Give the potion a dose of: RTG (10mg/kg). Sham operation group and model group did not do any treatment, only the same amount of physiological saline. A classical middle cerebral artery ischemia-reperfusion model was established to compare the neurological deficit scores in rats. The changes of cerebral infarct volume were measured by classical TTC staining. Immunohistochemical method was used to observe the changes of Caspase-3 expression in cerebral cortex of rats after cerebral ischemia and reperfusion, and the number of positive cells was counted under microscope. SPSS17.0 statistical software was used to carry out statistical analysis. The results were expressed as mean 鹵standard (`X 鹵s). The results showed that the differences were statistically significant by using LSD method or SNK method. Results 1 the neurological deficit score: there was no neurological deficit in the sham-operation group, and the model group showed some neurological deficit symptoms, such as body curling up or poor body balance. Rotate and fall to the left, or be unable to walk, etc. Compared with the model group, the score of neurological deficit symptoms in RTG intervention group was significantly lower (P0.05), showing a single neurological deficit symptom, or combined with two neurological deficit symptoms. However, there was no significant difference among subgroups of RTG at different time of action. 2. 2 TTC staining showed that there was no ischemic infarct in sham-operation group. The infarct focus of the model group was significantly lower than that of the model group (P0.05), but there was no significant difference between the subgroups of RTG at different time of action. Immunohistochemistry was used to detect sham-operation. A small amount of GFAP and apoptotic Caspase-3 positive cells were found in group A; The expression of GFAPand apoptotic Caspase-3 in intervention group was significantly lower than that in model group (P0.05), but there was no significant difference among subgroups of intervention group at different time of action. Conclusion (1) Retigabine can significantly decrease the neurological function score, reduce the volume of cerebral infarction, reduce the expression of GFAPand apoptosis Caspase-3 in cerebral infarction rats, and have protective effect on ischemic stroke in rats. The mechanism may be that retigabine can continuously inhibit the excitability of neurons and decrease the release of glutamate by retigabine, which can inhibit the excitability of neurons and inhibit the neuronal excitability by a large amount of potassium ion efflux during the depolarization of the cells. Therefore, the inflammatory reaction around cerebral infarction was further alleviated and the apoptosis of neurons was inhibited, but the time dependence needed to be studied.
【學(xué)位授予單位】:華北理工大學(xué)
【學(xué)位級別】:碩士
【學(xué)位授予年份】:2017
【分類號】:R743.3;R-332
【參考文獻】
相關(guān)期刊論文 前10條
1 王德龍;孫原;石秋艷;張春陽;楊騰騰;許士民;;瑞替加濱對小鼠急性腦缺血再灌注損傷的腦保護作用及機制研究[J];中華神經(jīng)醫(yī)學(xué)雜志;2016年10期
2 王德龍;石秋艷;孫原;楊騰騰;許世民;李艷玲;;M型鉀離子通道開放劑對腦梗死再灌注損傷的保護作用[J];西安交通大學(xué)學(xué)報(醫(yī)學(xué)版);2016年05期
3 江航;林江莉;;老年2型糖尿病患者下肢血管病變的多普勒超聲特征分析[J];臨床和實驗醫(yī)學(xué)雜志;2016年13期
4 李世平;朱伊璞;孫惠蓮;張月;孟然;檀國軍;;尤瑞克林治療急性腦梗死的單中心、前瞻性、隨機對照研究及對相關(guān)炎性細胞因子表達的影響[J];中風(fēng)與神經(jīng)疾病雜志;2016年03期
5 黃志英;張曉旭;孫文利;陳暢;李德鳳;方婧;付梅紅;劉慶山;顏天華;李韶菁;;缺血性腦中風(fēng)中與內(nèi)質(zhì)網(wǎng)應(yīng)激相關(guān)炎癥反應(yīng)研究進展[J];中國藥理學(xué)通報;2015年01期
6 王萍;張密霞;莊朋偉;盧志強;韓娟;張艷軍;;腦缺血再灌注損傷的炎癥反應(yīng)機制研究進展[J];天津中醫(yī)藥大學(xué)學(xué)報;2014年05期
7 于興兵;張賢春;謝振年;;地龍?zhí)崛∫褐委熖悄虿∽愕寞熜в^察[J];世界中醫(yī)藥;2014年02期
8 楊海玉;吳曉牧;劉勇;曾玉娥;;酒精性癡呆大鼠海馬神經(jīng)細胞凋亡與氧化應(yīng)激的研究[J];中風(fēng)與神經(jīng)疾病雜志;2013年11期
9 葉利斌;花愛遠;代波;盧婷婷;蔣桂秀;吳漢元;;腦缺血動物實驗研究進展[J];大眾科技;2013年08期
10 劉國政;;缺血性腦血管病的研究進展[J];實用心腦肺血管病雜志;2013年08期
相關(guān)博士學(xué)位論文 前2條
1 董銀鳳;Kir6.1/K-ATP通道在小鼠局灶性腦缺血再灌注損傷中的作用[D];南京醫(yī)科大學(xué);2013年
2 姜恩平;蒺藜皂苷對腦缺血再灌注損傷的保護作用及其機制的研究[D];吉林大學(xué);2010年
,本文編號:2143295
本文鏈接:http://sikaile.net/yixuelunwen/shenjingyixue/2143295.html